Apolipoprotéine M (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Apolipoprotéine M" in French language version.

refsWebsite

Global rank French rank

9nih.gov

4^th place

12^th place

7doi.org

2^nd place

3^rd place

2ensembl.org

1,626^th place

2,018^th place

2jbc.org

4,455^th place

1,915^th place

1jlr.org

low place

1sciencedirect.com

149^th place

80^th place

1pnas.org

1,293^rd place

405^th place

1biomedcentral.com

2,747^th place

1,253^rd place

1ahajournals.org

3,608^th place

659^th place

ahajournals.org

(en) Chirinos JA, Zhao L, Jia Y et al., « Reduced apolipoprotein M and adverse outcomes across the spectrum of human heart failure », Circulation, vol. 141, n^o 18,‎ 2020, p. 1463-76. (PMID 32237898, DOI 10.1161/CIRCULATIONAHA.119.045323, lire en ligne)

biomedcentral.com

lipidworld.biomedcentral.com

(en) Ruiz M, Okada H, Dahlbäck B, « HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium », Lipids Health Dis, vol. 16, n^o 1,‎ 2017, p. 36. (PMID 28179022, PMCID PMC5299634, DOI 10.1186/s12944-017-0429-2, lire en ligne)

doi.org

dx.doi.org

(en) Xu N, Dahlbäck B, « A novel human apolipoprotein (apoM) », J Biol Chem, vol. 274, n^o 44,‎ 1999, p. 31286–90. (PMID 10531326, DOI 10.1074/jbc.274.44.31286, lire en ligne)
(en) Christoffersen C, Nielsen LB, Axler O, Andersson A, Johnsen AH, Dahlbäck B, « Isolation and characterization of human apolipoprotein M-containing lipoproteins », J Lipid Res, vol. 47, n^o 8,‎ 2006, p. 1833–43. (PMID 16682745, DOI 10.1194/jlr.M600055-JLR200, lire en ligne)
(en) Elsøe S, Ahnström J, Christoffersen C et al., « Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL », Atherosclerosis, vol. 221, n^o 1,‎ 2012, p. 91–7. (PMID 22204862, DOI 10.1016/j.atherosclerosis.2011.11.031, lire en ligne)
(en) Liu M, Seo J, Allegood J, Bi X et al., « Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein », J Biol Chem, vol. 289, n^o 5,‎ 2014, p. 2801-14. (PMCID PMC3908412, DOI 10.1074/jbc.M113.499913, lire en ligne)
(en) Christoffersen C, Obinata H, Kumaraswamy SB et al., « Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M », Proc Natl Acad Sci U S A., vol. 108, n^o 23,‎ 2011, p. 9613-8. (PMID 21606363, PMCID PMC3111292, DOI 10.1073/pnas.1103187108, lire en ligne)
(en) Ruiz M, Okada H, Dahlbäck B, « HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium », Lipids Health Dis, vol. 16, n^o 1,‎ 2017, p. 36. (PMID 28179022, PMCID PMC5299634, DOI 10.1186/s12944-017-0429-2, lire en ligne)
(en) Chirinos JA, Zhao L, Jia Y et al., « Reduced apolipoprotein M and adverse outcomes across the spectrum of human heart failure », Circulation, vol. 141, n^o 18,‎ 2020, p. 1463-76. (PMID 32237898, DOI 10.1161/CIRCULATIONAHA.119.045323, lire en ligne)

ensembl.org

May2017.archive.ensembl.org

jbc.org

(en) Xu N, Dahlbäck B, « A novel human apolipoprotein (apoM) », J Biol Chem, vol. 274, n^o 44,‎ 1999, p. 31286–90. (PMID 10531326, DOI 10.1074/jbc.274.44.31286, lire en ligne)
(en) Liu M, Seo J, Allegood J, Bi X et al., « Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein », J Biol Chem, vol. 289, n^o 5,‎ 2014, p. 2801-14. (PMCID PMC3908412, DOI 10.1074/jbc.M113.499913, lire en ligne)

jlr.org

(en) Christoffersen C, Nielsen LB, Axler O, Andersson A, Johnsen AH, Dahlbäck B, « Isolation and characterization of human apolipoprotein M-containing lipoproteins », J Lipid Res, vol. 47, n^o 8,‎ 2006, p. 1833–43. (PMID 16682745, DOI 10.1194/jlr.M600055-JLR200, lire en ligne)

nih.gov

ncbi.nlm.nih.gov

« Publications PubMed pour l'Homme », sur National Center for Biotechnology Information, U.S. National Library of Medicine
« Publications PubMed pour la Souris », sur National Center for Biotechnology Information, U.S. National Library of Medicine
(en) Xu N, Dahlbäck B, « A novel human apolipoprotein (apoM) », J Biol Chem, vol. 274, n^o 44,‎ 1999, p. 31286–90. (PMID 10531326, DOI 10.1074/jbc.274.44.31286, lire en ligne)
(en) Christoffersen C, Nielsen LB, Axler O, Andersson A, Johnsen AH, Dahlbäck B, « Isolation and characterization of human apolipoprotein M-containing lipoproteins », J Lipid Res, vol. 47, n^o 8,‎ 2006, p. 1833–43. (PMID 16682745, DOI 10.1194/jlr.M600055-JLR200, lire en ligne)
(en) Elsøe S, Ahnström J, Christoffersen C et al., « Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL », Atherosclerosis, vol. 221, n^o 1,‎ 2012, p. 91–7. (PMID 22204862, DOI 10.1016/j.atherosclerosis.2011.11.031, lire en ligne)
(en) Liu M, Seo J, Allegood J, Bi X et al., « Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein », J Biol Chem, vol. 289, n^o 5,‎ 2014, p. 2801-14. (PMCID PMC3908412, DOI 10.1074/jbc.M113.499913, lire en ligne)
(en) Christoffersen C, Obinata H, Kumaraswamy SB et al., « Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M », Proc Natl Acad Sci U S A., vol. 108, n^o 23,‎ 2011, p. 9613-8. (PMID 21606363, PMCID PMC3111292, DOI 10.1073/pnas.1103187108, lire en ligne)
(en) Ruiz M, Okada H, Dahlbäck B, « HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium », Lipids Health Dis, vol. 16, n^o 1,‎ 2017, p. 36. (PMID 28179022, PMCID PMC5299634, DOI 10.1186/s12944-017-0429-2, lire en ligne)
(en) Chirinos JA, Zhao L, Jia Y et al., « Reduced apolipoprotein M and adverse outcomes across the spectrum of human heart failure », Circulation, vol. 141, n^o 18,‎ 2020, p. 1463-76. (PMID 32237898, DOI 10.1161/CIRCULATIONAHA.119.045323, lire en ligne)

pnas.org

(en) Christoffersen C, Obinata H, Kumaraswamy SB et al., « Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M », Proc Natl Acad Sci U S A., vol. 108, n^o 23,‎ 2011, p. 9613-8. (PMID 21606363, PMCID PMC3111292, DOI 10.1073/pnas.1103187108, lire en ligne)

sciencedirect.com

(en) Elsøe S, Ahnström J, Christoffersen C et al., « Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL », Atherosclerosis, vol. 221, n^o 1,‎ 2012, p. 91–7. (PMID 22204862, DOI 10.1016/j.atherosclerosis.2011.11.031, lire en ligne)